Northern Trust’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192K | Sell |
165,440
-343,641
| -68% | -$399K | ﹤0.01% | 3950 |
|
|
2025
Q1 | $687K | Sell |
509,081
-46,519
| -8% | -$62.8K | ﹤0.01% | 3437 |
|
|
2024
Q4 | $7.32M | Buy |
555,600
+53,584
| +11% | +$706K | ﹤0.01% | 2300 |
|
|
2024
Q3 | $5.63M | Buy |
502,016
+24,851
| +5% | +$279K | ﹤0.01% | 2409 |
|
|
2024
Q2 | $5.13M | Sell |
477,165
-18,124
| -4% | -$195K | ﹤0.01% | 2390 |
|
|
2024
Q1 | $7.38M | Sell |
495,289
-10,037
| -2% | -$150K | ﹤0.01% | 2240 |
|
|
2023
Q4 | $9.15M | Buy |
505,326
+370
| +0.1% | +$6.7K | ﹤0.01% | 2129 |
|
|
2023
Q3 | $8.76M | Buy |
504,956
+14,165
| +3% | +$246K | ﹤0.01% | 2096 |
|
|
2023
Q2 | $8.89M | Buy |
490,791
+387,124
| +373% | +$7.01M | ﹤0.01% | 2148 |
|
|
2023
Q1 | $2.76M | Buy |
103,667
+22,295
| +27% | +$593K | ﹤0.01% | 2804 |
|
|
2022
Q4 | $1.57M | Buy |
81,372
+25,071
| +45% | +$485K | ﹤0.01% | 3109 |
|
|
2022
Q3 | $1.18M | Buy |
56,301
+18,540
| +49% | +$387K | ﹤0.01% | 3260 |
|
|
2022
Q2 | $302K | Sell |
37,761
-175,908
| -82% | -$1.41M | ﹤0.01% | 3721 |
|
|
2022
Q1 | $1.5M | Sell |
213,669
-14,782
| -6% | -$104K | ﹤0.01% | 3243 |
|
|
2021
Q4 | $3.08M | Buy |
228,451
+3,631
| +2% | +$49K | ﹤0.01% | 2993 |
|
|
2021
Q3 | $3.8M | Buy |
224,820
+8,698
| +4% | +$147K | ﹤0.01% | 2912 |
|
|
2021
Q2 | $6.29M | Sell |
216,122
-5,970
| -3% | -$174K | ﹤0.01% | 2709 |
|
|
2021
Q1 | $8.74M | Buy |
222,092
+100,556
| +83% | +$3.95M | ﹤0.01% | 2382 |
|
|
2020
Q4 | $2.76M | Buy |
121,536
+322
| +0.3% | +$7.32K | ﹤0.01% | 3018 |
|
|
2020
Q3 | $2.75M | Buy |
+121,214
| New | +$2.75M | ﹤0.01% | 2891 |
|